

NCT02838810 comparison:

Summary:
CHIA has 14 criteria while your personal folder has 14 criteria
Total found criteria: 14/14
Total not Found: 0/14
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ CHB patients who had received single NAs for more  │ CHB patients who had received single NAs for more  │
│ than 12 months                                     │ than 12 months                                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hepatitis B e antigen (HBeAg)-negative             │ Hepatitis B e antigen (HBeAg)-negative             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hepatitis B surface antigen (HBsAg) positive and   │ Hepatitis B surface antigen (HBsAg) positive and   │
│ <1000 IU/mL                                        │ \<1000 IU/mL                                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hepatitis B virus DNA <100 IU/mL                   │ Hepatitis B virus DNA \<100 IU/mL                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with liver cirrhosis, Hepatocellular      │ Patients with liver cirrhosis, Hepatocellular      │
│ Carcinoma or AFP >2 ULN or other malignancies      │ Carcinoma or AFP \>2 ULN or other malignancies     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with other factors causing liver diseases │ Patients with other factors causing liver diseases │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pregnant and lactating women                       │ Pregnant and lactating women                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with concomitant HIV infection or         │ Patients with concomitant HIV infection or         │
│ congenital immune deficiency diseases              │ congenital immune deficiency diseases              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with diabetes, autoimmune diseases        │ Patients with diabetes, autoimmune diseases        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with important organ dysfunctions         │ Patients with important organ dysfunctions         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with serious complications (e.g.,         │ Patients with serious complications (e.g.,         │
│ infection, hepatic encephalopathy, hepatorenal     │ infection, hepatic encephalopathy, hepatorenal     │
│ syndrome, gastrointestinal bleeding.)              │ syndrome, gastrointestinal bleeding.)              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who receive antineoplastic or             │ Patients who receive antineoplastic or             │
│ immunomodulatory therapy in the past 12 months     │ immunomodulatory therapy in the past 12 months     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with a previous use of IFN anti hepatitis │ Patients with a previous use of IFN anti hepatitis │
│ B virus treatment or have NAs drug resistance      │ B virus treatment or have NAs drug resistance      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who can't come back to clinic for follow- │ Patients who can't come back to clinic for follow- │
│ up on schedule                                     │ up on schedule                                     │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 18 Years │
├───────────────────────────────────┤
│ Must have maximum age of 65 Years │
╘═══════════════════════════════════╛